Johnson & Johnson (J&J) has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Art Garfunkel, 83, talks exclusively with PEOPLE about taking a step back from his career to prioritize his health amid his ...

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

In individuals with psoriasis, the immune system malfunctions, causing inflammatory cells to accumulate in the dermis, the ...

If you’re experiencing a flaking, itching scalp, you may do a quick self-diagnosis of dandruff. But that flaking and itching ...

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. | Art Garfunkel is breaking the ...

The following is a summary of “’Ugh…how do you catch that?" - A qualitative study of the impact of psoriasis on social ...